Rhythm Pharmaceuticals logo
Rhythm Pharmaceuticals RYTM
$ 59.32 -0.07%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Rhythm Pharmaceuticals Income Statement 2011-2024 | RYTM

Annual Income Statement Rhythm Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.5 B 1.35 B 495 M 1.31 B 645 M 821 M 424 M - - - - - -

Shares

57.7 M 52.1 M 49.6 M 44.1 M 36.4 M 31 M 13.3 M - - - - - -

Historical Prices

43.4 25.9 9.98 29.7 23 26.9 29.1 - - - - - -

Net Income

-185 M -181 M -69.6 M -134 M -141 M -74.1 M -33.7 M -25.9 M -11.1 M - -21.4 M -18.1 M -

Revenue

77.4 M 23.6 M 3.15 M - - - - - - - - - -

Cost of Revenue

9.3 M 2.13 M 599 K - - - - 2.73 M 3.16 M - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-184 M -179 M -170 M -137 M -146 M -78.4 M -32.4 M -25.9 M -10.6 M - - - -

Interest Expense

13.9 M 5.2 M 100 M - - - - - - - - - -

EBITDA

-183 M -178 M -169 M -136 M -145 M -78 M -32.2 M -25.8 M -10.1 M - -21.4 M -18.1 M -

Operating Expenses

- - - - 146 M 78.4 M 32.4 M - - - - - -

General and Administrative Expenses

118 M 92 M 68.5 M 46.1 M 36.6 M 28.1 M 9.52 M 6.31 M 3.42 M - 3.43 M 2.46 M -

All numbers in USD currency

Quarterly Income Statement Rhythm Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

61.2 M 61 M 60.1 M 59.4 M 57.9 M 56.9 M 56.7 M 56.6 M 51.4 M 50.4 M 50.3 M 50.3 M 50.2 M 50.2 M 47.6 M 44.2 M 44.1 M 44.1 M 44 M 44 M 34.5 M 34.5 M 34.4 M 34.4 M 34.3 M 28 M 27.3 M 27.3 M 6.4 M 10.2 M 10.2 M 10.2 M 10.2 M - - - - - - - - - - - - - - - - - - - - - -

Net Income

-43.6 M -32.3 M -141 M - -44.2 M -46.7 M -52.2 M - -40.9 M -45 M -52.8 M - -35.1 M -35.4 M 43.8 M - -33.8 M -31.1 M -34.2 M -33 M -36 M -42.8 M -29 M -25.5 M -17.7 M -14.4 M -16.5 M -10.5 M -10 M -6.8 M -6.36 M -8.37 M -25.9 M -5.73 M -5.38 M - - - - - - - - - - - - - - - - - - - -

Revenue

33.3 M 29.1 M 26 M - 22.5 M 19.2 M 11.5 M - 4.28 M 9.07 M 1.5 M - 1.03 M 274 K 35 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

3.83 M 2.95 M 2.81 M - 2.41 M 2.24 M 1.42 M - 497 K 378 K 230 K - 222 K 137 K 4 K - - - - - - - - - - - - - - - - - 2.73 M - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-43.9 M -40.5 M -140 M - -44 M -46.6 M -52.5 M - -39.3 M -45.1 M -52.7 M - -44.2 M -40.4 M -34.4 M - -34.3 M -31.9 M -35.3 M - -37.1 M -44.1 M -30.5 M - -19.2 M -15 M -17 M - -8.29 M -6.75 M -6.39 M - -6.4 M - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

1.09 M 302 K 4.76 M - -159 K -17 K 3.06 M - 2.14 M 46 K -233 K - 100 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - -52.3 M - -39.1 M -45.1 M -52.6 M - -44.1 M -40.3 M -34.2 M - -33.8 M -31.6 M -35.1 M - -36.5 M -43.7 M -30.3 M - -19 M -14.9 M -16.9 M - -8.12 M -6.65 M -6.34 M - -6.31 M - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - 34.3 M 31.9 M 35.3 M 34.2 M 37.1 M 44.1 M 30.5 M 27.2 M 19.2 M 15 M 17 M 11 M 8.29 M 6.75 M 6.39 M 8.38 M 6.4 M 5.74 M 5.39 M - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

35.4 M 36.4 M 34.4 M - 30.5 M 30 M 24.6 M - 21.9 M 22.3 M 21.4 M - 17.5 M 15.5 M 14.5 M - 11.3 M 8.92 M 12.8 M - 10.5 M 8.84 M 7.76 M - 8.54 M 6.44 M 4.72 M - 2.32 M 1.36 M 1.52 M - 982 K - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency